BioLoomics, Inc.

📍 Boulder, United States🗓 Founded 2019👥 12 employees💰 Last funded Mar 2023
Biotechnology Research🌐 BioLoomics.com
Website LinkedIn
BioLoomics is a preclinical stage biotechnology company leveraging directed evolution of antibodies in human cells to create target degrading antibodies. Our proprietary tech combines single-cell bioassay engineering, robotics, and ML. #synbio #directedevolution #antibodies
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2019
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Hong Kong SAR
1
Frequently asked questions
Who invested in BioLoomics, Inc.?
BioLoomics, Inc. has 1 investors on record on gritt.io, 1 mid-stage.
When did BioLoomics, Inc. last raise funding?
The most recent investment in BioLoomics, Inc. recorded on gritt.io was in March 2023.
When was BioLoomics, Inc. founded?
BioLoomics, Inc. was founded in 2019.
What industry is BioLoomics, Inc. in?
BioLoomics, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is BioLoomics, Inc. based?
BioLoomics, Inc. is headquartered in Boulder, United States.